By
Trending Posts
Eli Lilly and Genetic Leap Forge $409M Strategic…
New York – Sept 24 2024 Eli Lilly and Company (NYSE: LLY) has entered into a landmark $409…
Rakovina Therapeutics and Variational AI Partner to Advance…
Vancouver, BC – September 17, 2024 Rakovina Therapeutics Inc. (TSX-V: RKV), a Canadian biopharmaceutical company focused on developing…
Gilead Expands AI-Driven Drug Discovery Capabilities Through Strategic…
BURLINGAME, California – Sept 10, 2024 Gilead Sciences, Inc. (Nasdaq: GILD) and Genesis Therapeutics have entered into a…
Sanofi Taps Atomwise in $1B+ AI Drug Pact…
Key Highlights San Francisco — Atomwise, a pioneer in artificial intelligence for small molecule drug discovery, has entered…
How Stryker’s Acquisition of care.ai Strengthens Its Push…
Stryker to acquire care.ai to elevate virtual care workflows and expand its healthcare IT leadership Portage, Michigan –…
AI-Powered Clinical Trials: How Unlearn AI, AbbVie, and…
July 30, 2024 Artificial intelligence (AI) is revolutionizing clinical trials, offering greater efficiency and precision. At the Alzheimer’s…
CytoReason Raises $80M from OurCrowd, NVIDIA, Pfizer &…
New funding will scale CytoReason’s AI platform, expand disease models, and support a new office in Cambridge, MA.…
GSK Partners with Ochre Bio in $37.5 Million…
London, UK – June 12 2024 GSK has entered into a $37.5 million strategic partnership with Ochre Bio…
Sanofi, Formation Bio, and OpenAI Forge Strategic Alliance…
Paris, New York, N.Y., and San Francisco, CA — May 21, 2024 Sanofi, Formation Bio, and OpenAI have…
Trending Posts
Latest Stories
How Will BioNTech’s Patent Settlement Impact the Future of mRNA COVID-19 and Influenza Vaccines Globally?
Key Highlights Resolving Patent Litigation and Securing LicensesBioNTech SE and Pfizer reached agreements with CureVac…
Could Eli Lilly’s AI-Driven Innovation Accelerate Biopharma Growth to $62 Billion in 2025?
Key Highlights Robust Revenue Growth Powered by AI-Driven ProductsIn Q2 2025, Eli Lilly delivered impressive…
Could Chai’s $70 Million OpenAI-Backed Funding Propel the Next Leap in AI-Engineered Drug Discovery Success?
Key Highlights Breakthrough Funding and Industry BackingThe Series A round brings Chai Discovery’s total capital…
Is Illinois’ Ban on AI in Mental Healthcare a Turning Point for Human-Centered Therapy Regulation in the U.S.?
Key Highlights Background and Impetus for the BanDriven by incidents where AI chatbots posed risks—including…
Gallery
